Hyderabad: Aurobindo Pharma Limited, a world-leading marketer and manufacturer of generic pharmaceuticals and active pharmaceutical ingredients has announced the signing of a definitive agreement to acquire from Apotex International Inc. ("Apotex"), its commercial operations and certain supporting infrastructure in five European countries. Closing of the transaction is conditional on the receipt of competition clearances for the transaction by the Dutch and Polish authorities.